Skip to main content
OpenTrials
Completed

NCT Number: NCT02214043

Clinical Characteristics of Acute Pulmonary Embolism in Chinese Population

There are no special clinical characteristics of acute pulmonary embolism in Chinese population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pulmonary Embolism Cardiovascular Diseases Embolism Embolism and Thrombosis Lung Diseases Respiratory Tract Diseases Vascular Diseases

Age range

15 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Center of pumonary vascular diseases

Beijing, 100037, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • the symptomatic acute PE confirmed by objective examination

Exclusion criteria

  • congestive heart failure
  • chronic obstructive pulmonary disease;
  • a prior documented episode of PE or DVT
  • renal dysfunction;
  • a life expectancy of less than 6 months

Treatment and study plan

Primary outcomes

  1. The primary end point of the present study was symptomatic, objectively confirmed recurrent fatal or nonfatal VTE.

    Time frame: 60 months

Secondary outcomes

  1. The second end point was death (all cause death and PE-related death).

    Time frame: 60 months

    If the participant died, the relatives need provided the written medical record on the death.

Sponsors and collaborators

Lead sponsor

Chinese Pulmonary Vascular Disease Research Group

Other

Registry information

Important dates

Study start
2012
Primary completion
2017
Study completion
2017
First posted
Aug 12, 2014
Registry last updated
Jan 30, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.